undergradly.
Major · Biological Sciences

Applying biology, biochemistry, and genetics to drug development and industrial production

Biotechnology (CIP 26.1201) applies biological sciences, biochemistry, and genetics to commercial development of agricultural, environmental, clinical, and industrial products. About 1,104 students complete it across 146 institutions; bachelor’s grads earn $76,773 — strong wages reflecting biotech-industry hiring at the bachelor’s level.

Schools offering
146
Annual completions
1,104
Typical degree level
Associate's + Bachelor's
Median earnings (5yr)
$77k

About this major

Biotechnology (CIP 26.1201) applies the biological sciences, biochemistry, and genetics to the commercial development of agricultural, environmental, clinical, and industrial products. The CIP definition spans bioinformatics, gene identification, phylogenetics and comparative genomics, bioinorganic chemistry, immunoassaying, DNA sequencing, xenotransplantation, genetic engineering, industrial microbiology, drug and biologic development, enzyme-based production processes, patent law, biotechnology management and marketing, applicable regulations, and biotechnology ethics. Coursework typically combines a science core (general and organic chemistry, biology, biochemistry, microbiology, genetics, cell biology) with applied biotechnology (recombinant DNA techniques, fermentation and bioprocessing, immunoassays, bioinformatics) plus business-adjacent material on patent law, FDA and USDA regulation, and biotech ethics.

The major fits students drawn to applied biology — using molecular techniques to develop drugs, agricultural products, industrial enzymes, and biologic therapeutics — rather than the mechanism-focused academic track that biochemistry students typically choose. It rewards strong chemistry through organic and biochemistry, comfort with hands-on bioprocess and lab work, and the kind of attention to detail that pharmaceutical and biotech regulatory environments demand. Day-to-day at the upper-undergraduate level mixes molecular biology lab work, applied bioprocessing exercises, scientific writing for regulatory and patent contexts, and (for the strongest students) industry internships or co-ops at biotech firms during junior and senior years.

One grounded observation about scale and trajectory: 1,104 students complete this CIP across 146 institutions, with bachelor’s grads earning $76,773 — meaningfully stronger than the $66,359 reported for biochemistry and molecular biology, reflecting biotech-industry concentration in high-cost-of-living metros and the applied curriculum’s direct industry positioning. Top producers include University of Houston (84), UC Davis (70), Brigham Young (36), Cal Poly Pomona (34), Rutgers New Brunswick (34), and Rochester Institute of Technology (29). The packet’s named occupations include Biological scientists, all other ($93,330, 1.2% growth, bachelor’s entry), Natural sciences managers ($161,180, mid-career), and Biological science teachers postsecondary ($83,460, doctoral entry). Realistic bachelor’s-entry destinations include research associate or scientist I roles at biotech and pharma firms, bioprocess engineering, biologics manufacturing, quality control and quality assurance, regulatory affairs, and CRO clinical research associate work. Geographic concentration is heavy: Boston-Cambridge, Bay Area, San Diego, Research Triangle Park, and Maryland’s biotech corridor anchor most hiring.

Section 3 · Careers

Where this major leads

Occupations most often associated with this major, from the federal BLS+O*NET crosswalk. Job-growth projections and median wages are national.

Occupation Median wage Job growth Typical education
Natural sciences managers $161k +3.7% Bachelor's degree
Biological science teachers, postsecondary $83k +7.3% Doctoral or professional degree
Biological scientists, all other $93k +1.2% Bachelor's degree
Section 4 · Earnings

Earnings at a glance

Median graduate earnings from the federal College Scorecard, 5 and 10 years out.

Median 5-year earnings

$77k

Who this major is for

Good signs this major fits: you’re drawn to applied biology and the commercial development of drugs, biologics, agricultural products, or industrial enzymes rather than mechanism-focused academic biochemistry; you have strong chemistry performance through organic and biochem and can handle the hands-on bioprocess and molecular-biology lab work the curriculum requires; you’re comfortable with the regulatory and patent-law content that distinguishes this CIP from pure biology majors; you can relocate to one of the dense biotech-hiring metros (Boston-Cambridge, Bay Area, San Diego, Research Triangle, Maryland I-270 corridor); and you appreciate that the bachelor’s supports a real industry career without mandatory graduate school, with optional master’s or PhD ramps later.

Reasons to pause: biotech employment is heavily geographically concentrated — outside the top metros, hiring is meaningfully thinner, and the headline $76,773 wage data reflects industry-concentrated geography. Recent biotech hiring has been uneven across the cycle; verify your target program’s placement outcomes and industry feeder rates before assuming the wage data applies. If your real interest is mechanism-focused research and pre-medical or PhD work, Biochemistry and Molecular Biology (CIP 26.0210, 1,117 completions) better positions you for those tracks. The closely related Biology, General CIP (26.0101, 83,027 completions) offers more flexibility but less direct biotech-industry signaling. Plan whether industry internships or co-ops are baked into your target program — graduates with internship experience consistently outperform those without on industry placement.

Section 6 · Where to study

Top colleges for Biotechnology

Ranked by annual completions at the associate's or bachelor's level — a proxy for program scale.

College Location Assoc. Bach. Total
University of Houston Houston, TX 0 84 84
University of California-Davis Davis, CA 0 70 70
Brigham Young University Provo, UT 0 36 36
California State Polytechnic University-Pomona Pomona, CA 0 34 34
Rutgers University-New Brunswick New Brunswick, NJ 0 34 34
University of Kentucky Lexington, KY 0 33 33
California State University-San Marcos San Marcos, CA 0 29 29
Rochester Institute of Technology Rochester, NY 0 29 29
Northeastern University Professional Programs Boston, MA 0 25 25
Utah Valley University Orem, UT 0 24 24
Section 9 · Frequently asked

Common questions

What does this major actually cover?
The CIP applies biology, biochemistry, and genetics to commercial product development. Coursework typically combines a science core (general and organic chemistry, biology, biochemistry, microbiology, genetics, cell biology) with applied biotechnology coursework (bioinformatics, gene identification, DNA sequencing, immunoassays, recombinant DNA techniques, fermentation and bioprocessing) plus business-adjacent material covering biotechnology management, marketing, patent law, applicable regulations (FDA, USDA), and biotechnology ethics. Most programs include an internship or co-op at a biotech firm.
How does this differ from biochemistry and molecular biology (CIP 26.0210)?
Biochemistry and Molecular Biology (26.0210, 1,117 completions) is more academic and mechanism-focused — protein folding, gene expression, cellular regulation. Biotechnology (26.1201, 1,104 completions) is more applied and industry-focused — using molecular techniques to develop drugs, agricultural products, industrial enzymes, and biologic therapeutics. The labor market values biotechnology more for direct industry entry into drug development, bioprocessing, and biomanufacturing roles. Biochemistry positions students better for pre-medical and PhD-track work.
What jobs do graduates land?
The packet names three occupations: Natural sciences managers ($161,180, 3.7% growth, mid-career role), Biological scientists, all other ($93,330, 1.2% growth, bachelor’s entry), and Biological science teachers postsecondary ($83,460, 7.3% growth, doctoral entry). Realistic bachelor’s-entry destinations include research associate or scientist I roles at biotech and pharma firms ($55,000-$75,000), bioprocess engineering and manufacturing roles in biologics production, quality control or quality assurance, regulatory affairs entry positions, biotech business development support, and clinical research associate work at CROs.
Why is the wage stronger than biology or biochemistry?
The packet shows $76,773 for biotechnology versus $66,359 for biochemistry and molecular biology — a meaningful gap. Three factors contribute: biotech-industry hiring concentrates in high-cost-of-living metros where wages run higher; the applied curriculum prepares graduates for direct industry roles rather than the research-tech track that biochemistry graduates often start on; and biotech firms compete actively for graduates with bioprocess, manufacturing, and bioinformatics skills. Geographic concentration matters: Boston-Cambridge, Bay Area, San Diego, Research Triangle, and Maryland’s biotech corridor offer the densest hiring and highest wages.
Should I plan on graduate school?
Less mandatory than for biochemistry — the bachelor’s alone supports a real industry career, particularly in bioprocess engineering, manufacturing, regulatory affairs, and quality functions. That said, advancing into research-scientist roles (designing experiments, leading projects) typically requires a master’s or PhD. Many biotechnology graduates work for 2-5 years in industry, then return for a PhD, MBA, master’s in regulatory affairs, or master’s in bioengineering. The bachelor’s functions as a strong floor with multiple ramp options.
Where do graduates actually settle geographically?
Biotech hiring is heavily concentrated. Boston-Cambridge (Genentech, Vertex, Moderna, Sanofi, Takeda) and the Bay Area (Genentech, Gilead, Amgen, plus major pharma) anchor the densest markets. San Diego (Illumina, Pfizer Vaccines, Novartis, BioMarin) and Research Triangle Park in North Carolina (Biogen, Pfizer, plus a heavy CRO presence) round out the top tier. Maryland’s I-270 corridor (MedImmune/AstraZeneca, NIH-adjacent firms), Seattle, Indianapolis (Lilly), and New Jersey’s pharma corridor offer secondary markets. Outside these regions, biotech employment is meaningfully thinner — plan for relocation as part of the career calculus.